Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PharmVar GeneFocus: SLCO1B1
Laura B. Ramsey, Li Gong, Seung‐been Lee, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 4, pp. 782-793
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Membrane transporters in drug development and as determinants of precision medicine
Aleksandra Galetin, Kim L. R. Brouwer, Donald Tweedie, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 255-280
Closed Access | Times Cited: 86
Silencing drug transporters in human primary muscle cells modulates atorvastatin pharmacokinetics: A pilot study
Emilia Hoste, Louise Deldicque, Giulio G. Muccioli, et al.
British Journal of Pharmacology (2025)
Closed Access | Times Cited: 1
Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment
Magnus Ingelman‐Sundberg, Munir Pirmohamed
Journal of Internal Medicine (2024) Vol. 295, Iss. 5, pp. 583-598
Open Access | Times Cited: 6
Effect of Staggered vs. Simultaneous Co-Administration of Bempedoic Acid on Pharmacokinetics of Pravastatin: Randomized, Cross-Over Clinical Trial in Healthy Volunteers
Felicitas Stoll, Salvatore Amato, Max Sauter, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 60-60
Open Access
Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19
Hye-Jung Park, Sangho Lee, Pureum Kang, et al.
Archives of Pharmacal Research (2025)
Closed Access
Discussion on the optimization of personalized medication using information systems based on pharmacogenomics: an example using colorectal cancer
Mengying Yuan, Zheng Yu, Fei Wang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
The impact of SLCO1B1 polymorphisms on homocysteine concentrations: evidence for a stronger association in men
Xinyuan Hu, Yonghua Jiang
Frontiers in Nephrology (2025) Vol. 4
Open Access
Pharmacogenetic features of angiotensin-converting enzyme inhibitors
Б. И. Кантемирова, O. V. Komarova, Alexandra Romanová
Pharmacogenetics and Pharmacogenomics (2025), Iss. 2, pp. 19-28
Open Access
Association of SLCO1B1 genetic variants with neonatal hyperbilirubinemia: a consolidated analysis of 36 studies
Hanieh Talebi, Seyed Alireza Dastgheib, Maryam Vafapour, et al.
BMC Pediatrics (2025) Vol. 25, Iss. 1
Open Access
The frequency of rs2231142 in ABCG2 among Asian subgroups: implications for personalized rosuvastatin dosing
Khalifa Alrajeh, Youssef M. Roman
Pharmacogenomics (2023) Vol. 24, Iss. 1, pp. 15-26
Closed Access | Times Cited: 11
Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe
Jonny Kinzi, Markus Grube, Isabell Seibert, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 10
Open Access | Times Cited: 3
A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance
Margherita Bigossi, Cyrielle Maroteau, Adem Y. Dawed, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 6, pp. 536-545
Open Access | Times Cited: 7
Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function
Kreetta Hämäläinen, Päivi Hirvensalo, Mikko Neuvonen, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 3
Open Access | Times Cited: 2
Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting Polypeptides
Christine C. Orozco, Mikko Neuvonen, Yi‐An Bi, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 6, pp. 3020-3032
Closed Access | Times Cited: 6
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin
Minna Lehtisalo, E. Katriina Tarkiainen, Mikko Neuvonen, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 115, Iss. 1, pp. 71-79
Open Access | Times Cited: 6
Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactions
Jaime I. Sainz de Medrano, Merçè Brunet
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2023) Vol. 4, Iss. 4, pp. 341-352
Open Access | Times Cited: 5
The Frequency of Major ABCG2 , SLCO1B1 and CYP2C9 Variants in Asian, Native Hawaiian and Pacific Islander Women Subgroups: Implications for Personalized Statins Dosing
Khalifa Alrajeh, Ola Al-Azzeh, Youssef M. Roman
Pharmacogenomics (2023) Vol. 24, Iss. 7, pp. 381-398
Open Access | Times Cited: 4
Various effects of repeated rifampin dosing on coproporphyrin levels in humans
Jonny Kinzi, Markus Grube, Karin Brecht, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 11, pp. 2289-2298
Open Access | Times Cited: 4
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism
Chang‐Keun Cho, Ju Yeon Mo, Eunvin Ko, et al.
Archives of Pharmacal Research (2023) Vol. 47, Iss. 2, pp. 95-110
Closed Access | Times Cited: 4
Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population
Mais N. Alqasrawi, Zeina N. Al-Mahayri, Hiba Alblooshi, et al.
Current Vascular Pharmacology (2024) Vol. 22, Iss. 3, pp. 218-229
Closed Access | Times Cited: 1
Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults
Mollie Walton, Jonathan Wagner
Genes (2024) Vol. 15, Iss. 3, pp. 379-379
Open Access | Times Cited: 1
SLCO1B1 Exome Sequencing and Statin Treatment Response in 64,000 UK Biobank Patients
Deniz Türkmen, Jack Bowden, Jane Masoli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4426-4426
Open Access | Times Cited: 1
Transporter Genes and statin-induced Hepatotoxicity
Seo-A Choi, Jung Sun Kim, Yoon‐A Park, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 1
Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy
José J.G. Marı́n, María A. Serrano, Elisa Herráez, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
PharmVar GeneFocus: CYP4F2
Pablo Zubiaur, Cristina Rodríguez‐Antona, Erin C. Boone, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 4, pp. 963-975
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top